Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of brodalumab, compared to
placebo, in subjects with psoriatic arthritis. The key secondary objective is to evaluate the
efficacy of brodalumab compared to placebo at week 16. The safety objective of this study is
to evaluate the safety profile of brodalumab in subjects with psoriatic arthritis.